hydroxychloroquine

Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia

A. D’Alessio, M. Cottini, C. Lombardi, M. Uccelli, F. Bracchi, G. Cesana, D. Di Mauro, A. Fargnoli, C. Giussani, F. Martini, M. Motta, S. Olmi, N. Sertori, M. Taverna & P. Del Poggio · Asian Journal of Medicine and Health · 2021

Background: Hydroxychloroquine (HCQ) has been used against SARS-CoV-2, but large non randomized studies failed to show any clinical benefit. However, in these studies the drug was started in the hospital setting, a significant time after the onset of symptoms. Aim of the Study: t...

Open access Research Article 10.9734/ajmah/2021/v19i230301

Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19

Violaine Guérin, Pierre Lévy, Jean-Louis Thomas, Thierry Lardenois, Philippe Lacrosse, Emmanuel Sarrazin, Natacha Regensberg-de Andreis & Martine Wonner · Asian Journal of Medicine and Health · 2020

Aims: The challenge regarding COVID-19 is to prevent complications and fatal evolution. Azithromycin (AZM) and hydroxychloroquine (HCQ) have proven their antiviral effect in vitro. We aimed to assess the efficacy and safety of AZM alone or combined to HCQ, prescribed, at an early...

Open access Research Article 10.9734/ajmah/2020/v18i730224